Clinical Trial Update: To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

View source ↗

Summary

This clinical trial update indicates that the study evaluating the effectiveness and safety of Zepzelca (lurbinectedin) in adults with extensive-stage small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Zepzelca (lurbinectedin)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Extensive-stage Small-cell Lung Cancer | Status: COMPLETED